Immunocapture-LC/MS-Based Target Engagement Measurement in Tumor Plasma Membrane

Analytical Chemistry
|October 30, 2018
PubMed

Insights

A new assay platform using immunocapture-liquid chromatography mass spectrometry (IC-LC/MS) measures drug target engagement directly on tumor cell membranes. This method enhances understanding of drug efficacy for targeted therapies.

Area of Science:

  • Biomedical Science
  • Analytical Chemistry
  • Pharmacology

Background:

  • Immunocapture-liquid chromatography mass spectrometry (IC-LC/MS) is crucial for assessing drug exposure and target engagement in targeted therapies.
  • Current methods often analyze systemic circulation or tissue homogenates, but direct measurement at the cell plasma membrane, the primary drug action site, is preferred.
  • Existing IC-LC/MS methodologies for plasma membrane analysis in tissue samples are limited.

Purpose of the Study:

  • To develop and validate an IC-LC/MS assay platform for quantifying target engagement specifically at the tumor plasma membrane.
  • To assess the in vivo target engagement of an antibody-drug conjugate (ADC) targeting guanylyl cyclase C (GCC) in tumor samples.
  • To improve the understanding of pharmacokinetic/pharmacodynamic (PK/PD) relationships for enhanced antitumor efficacy.

Main Methods:

  • Development of an IC-LC/MS assay platform for analyzing tumor plasma membrane preparations.
  • Utilizing fully human IgG1 monoclonal antibody-based ADC treatment in tumor samples expressing GCC.
  • Differentiating between total and target-drug bound GCC fractions to calculate in vivo target engagement with minimal equilibrium shift.

Main Results:

  • Successfully established an IC-LC/MS assay platform for tumor plasma membrane analysis.
  • Demonstrated the ability to accurately measure in vivo target engagement of an ADC targeting GCC.
  • The method minimizes potential equilibrium shifts between cell surface and organelle proteins.

Conclusions:

  • The developed IC-LC/MS assay provides a robust method for assessing in vivo target engagement at the tumor plasma membrane.
  • This approach offers a more precise understanding of PK/PD relationships for targeted therapies.
  • The methodology has the potential to optimize therapeutic strategies for improved antitumor efficacy.

Related Concept Videos

Enlargement of the Plasma Membrane01:22

Enlargement of the Plasma Membrane

Cell division and enlargement are processes that require precise control. The control ensures that cell division cannot proceed unless the cell has grown to a specific size. A spherical, dividing cell requires an approximately 1.6X increase in its surface area to double its volume. The secretory pathway also has a significant role in cell membrane enlargement. Secretory vesicles that bud off from the Golgi apparatus and later fuse with the plasma membrane during exocytosis are a major source of...
2.4K
Plasma Membrane in Bacteria and Archaea01:27

Plasma Membrane in Bacteria and Archaea

The plasma membrane is an essential cellular structure responsible for maintaining cellular integrity and regulating the selective transport of molecules. While bacteria and archaea share the fundamental function of plasma membranes, their structural and molecular differences reflect adaptations to distinct ecological and physiological challenges.Bacterial Plasma MembranesBacterial plasma membranes are predominantly composed of phospholipids with fatty acid chains ester-linked to a glycerol...
1.8K
Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
18.9K
Introduction to Membrane Proteins01:16

Introduction to Membrane Proteins

The cell membrane, or plasma membrane, is an ever-changing landscape. It is described as a fluid mosaic where various macromolecules are embedded in the phospholipid bilayer. Among the macromolecules are proteins. The protein content varies across cell types. For example, mitochondrial inner membranes contain ~76% protein content, while myelin contains ~18% protein content. Individual cells contain many types of membrane proteins—red blood cells contain over 50—and different cell...
81.1K
Composition of Blood Plasma01:24

Composition of Blood Plasma

Blood plasma is a fluid that contains approximately 92% water and 8% solutes. The solutes include various types of proteins, which constitute about 7% of the total solutes in the plasma. The high-molecular-weight proteins—albumins, globulins, and fibrinogen—are essential to plasma function. Albumins, making up about 60% of the plasma proteins, maintain the osmotic balance within blood vessels by preventing excessive water leakage. Additionally, albumins serve as carrier proteins,...
8.5K
What are Membranes?01:54

What are Membranes?

A key characteristic of life is the ability to separate the external environment from the internal space. To do this, cells have evolved semi-permeable membranes that regulate the passage of biological molecules. Additionally, the cell membrane defines a cell’s shape and interactions with the external environment. Eukaryotic cell membranes also serve to compartmentalize the internal space into organelles, including the endomembrane structures of the nucleus, endoplasmic reticulum and...
190.7K